Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's Disease
Eric McDade,Haiyan Liu,Quoc Bui,Jason Hassenstab,Brian Gordon,Tammie Benzinger,Yuanyuan Shen,Jigyasha Timsina,Lihua Wang,Yun Ju Sung,Celeste Karch,Alan Renton,Alisha Daniels,John Morris,Chengjie Xiong,Laura Ibanez,Richard Perrin,Jorge J Llibre-Guerra,Gregory Day,Charlene Supnet-Bell,Xiong Xu,Sarah Berman,Jasmeer Chhatwal,Takeshi Ikeuchi,Kensaku Kasuga,Yoshiki Niimi,Edward Huey,Peter Schofield,William Brooks,Natalie Ryan,Mathias Jucker,Christoph Laske,Johannes Levin,Jonathan Vöglein,Jee Hoon Roh,Francisco Lopera,Randall Bateman,Carlos Cruchaga
DOI: https://doi.org/10.21203/rs.3.rs-4202125/v1
2024-07-23
Abstract:This study explored the role of the ubiquitin-proteasome system (UPS) in dominantly inherited Alzheimer's disease (DIAD) by examining changes in cerebrospinal fluid (CSF) levels of UPS proteins along with disease progression, AD imaging biomarkers (PiB PET, tau PET), neurodegeneration imaging measures (MRI, FDG PET), and Clinical Dementia Rating® (CDR®). Using the SOMAscan assay, we detected subtle increases in specific ubiquitin enzymes associated with proteostasis in mutation carriers (MCs) up to two decades before the estimated symptom onset. This was followed by more pronounced elevations of UPS-activating enzymes, including E2 and E3 proteins, and ubiquitin-related modifiers. Our findings also demonstrated consistent correlations between UPS proteins and CSF biomarkers such as Aβ42/40 ratio, total tau, various phosphorylated tau species to total tau ratios (ptau181/T181, ptauT205/T205, ptauS202/S202, ptauT217/T217), and MTBR-tau243, alongside Neurofilament light chain (NfL) and the CDR®. Notably, a positive association was observed with imaging markers (PiB PET, tau PET) and a negative correlation with markers of neurodegeneration (FDG PET, MRI), highlighting a significant link between UPS dysregulation and neurodegenerative processes. The correlations suggest that the increase in multiple UPS proteins with rising tau levels and tau-tangle associated markers, indicating a potential role for the UPS in relation to misfolded tau/neurofibrillary tangles (NFTs) and symptom onset. These findings indicate that elevated CSF UPS proteins in DIAD MCs could serve as early indicators of disease progression and suggest a link between UPS dysregulation and amyloid plaque, tau tangles formation, implicating the UPS as a potential therapeutic target in AD pathogenesis.